Von Willebrand antigen II (vWAgII) distinguishes acquired von Willebrand Syndrome (AvWS) due to decreased synthesis from that due to increased clearance of vWF. † 795

被引：0
|
作者：
J Paul Scott
Joan Cox Gill
Elizabeth A Vokac
Kenneth D Friedman
Robert R Montgomery
机构：
[1] Blood Research Institute,
[2] Pediatrics,undefined
[3] Medical College of Wisconsin,undefined
来源：
Pediatric Research | 1998年 / 43卷 / Suppl 4期
关键词：
D O I：
10.1203/00006450-199804001-00816
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：138 / 138
相关论文
共 25 条
  • [1] The von Willebrand factor propolypeptide, von Willebrand antigen II (vWAgII), distinguishes acquired von Willebrand syndrome (AvWS) due to decreased synthesis of von Willebrand factor (vWF) from AvWS due to increased clearance of vWF.
    Scott, JP
    Vokac, EA
    Schroeder, T
    Foster, PA
    Gill, JC
    Montgomery, PR
    [J]. BLOOD, 1995, 86 (10) : 773 - 773
  • [2] A role for the VWF propeptide (VWF:pp) assay in the diagnosis of acquired von Willebrand syndrome (AVWS)
    Gandhi, T.
    Yee, T.
    Riddell, A.
    [J]. HAEMOPHILIA, 2008, 14 : 114 - 114
  • [3] VWF propeptide (VWFpp) demonstrates the relationship between antibody-mediated VWF clearance and VWF production in the phenotypic expression in a case of acquired von Willebrand Syndrome (aVWS)
    Lee, Adrienne
    Sinclair, Gary
    Poon, Man-Chiu
    [J]. HAEMOPHILIA, 2014, 20 : 113 - 114
  • [4] Aortic stenosis and bleeding risk due to acquired Von Willebrand syndrome
    Perez, M. Gomez
    Serrat, R.
    Cladellas, M.
    Molina, L.
    Roqueta, C.
    Manteiga, R.
    Bruguera, J.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 285 - 285
  • [5] DDAVP versus vWF-Containing factor concentrate in a patient with ET associated acquired von Willebrand syndrome (AVWS).
    Kruse-Jarres, Rebecca
    Leissinger, Cindy A.
    [J]. BLOOD, 2006, 108 (11) : 92B - 92B
  • [6] Response to DDAVP in acquired von Willebrand syndrome due to IgM monoclonal gammopathy
    Staritz, P.
    Lages, P.
    Zimmermann, R.
    Huth-Kuehne, A.
    [J]. HAMOSTASEOLOGIE, 2010, 30 (4A): : S177 - S178
  • [7] Acquired von Willebrand Syndrome due to Aortic Valve Stenosis in a Case with Antiphospholipid Antibody
    Tanaka, Hiroaki
    Nagai, Yurie
    Kuwabara, Chihiro
    Shimizu, Ryo
    Umeki, Akihide
    Yamamoto, Tetsufumi
    [J]. INTERNAL MEDICINE, 2018, 57 (11) : 1641 - 1644
  • [8] Management of multiple cerebral embolisms due to polycythemia vera with acquired von Willebrand syndrome
    Watanabe, Masashi
    Ohtsubo, Haruki
    Shiraoka, Akira
    Kyoraku, Itaru
    Okamoto, Kensho
    [J]. NEUROLOGY AND CLINICAL NEUROSCIENCE, 2024,
  • [9] Von Willebrand Factor (VWF) Propeptide and Factor VIII (FVIII) Levels Identify the Contribution of Decreased Synthesis and/or Increased Clearance Mechanisms in the Pathogenesis of Type 1 Von Willebrand Disease (VWD) in the Zimmerman Program
    Haberichter, Sandra L.
    Christopherson, Pamela A.
    Flood, Veronica H.
    Gill, Joan Cox
    Friedman, Kenneth D.
    Montgomery, Robert R.
    [J]. BLOOD, 2016, 128 (22)
  • [10] Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series
    Casonato, Alessandra
    Gallinaro, Lisa
    Cattini, Maria Grazia
    Sartorello, Francesca
    Pontara, Elena
    Padrini, Roberto
    Bertomoro, Antonella
    Daidone, Viviana
    Pagnan, Antonio
    [J]. TRANSLATIONAL RESEARCH, 2010, 155 (04) : 200 - 208
123